Corporate News 02-Nov-21
ANG Lifesciences receives approval for migration to Main Board of BSE
ANG Lifesciences India has received in-principal approval for migration of equity shares of the company from BSE SME Platform to Main Board of BSE.
Previous News
ANG Lifesciences India to announce Quarterly Result
( Corporate News - 24-May-22 09:55 )
Board of ANG Lifesciences India recommends First Interim Dividend
( Corporate News - 26-Oct-21 09:58 )
ANG Lifesciences India reports consolidated net loss of Rs 4.61 crore in the March 2023 quarter
( Results - Announcements 31-May-23 14:54 )
ANG Lifesciences India schedules AGM
( Corporate News - 11-Sep-19 12:17 )
ANG Lifesciences India to hold board meeting
( Corporate News - 29-Mar-23 16:35 )
Nucleus Software Exports Ltd leads gainers in 'B' group
( Hot Pursuit - 16-Feb-23 12:15 )
ANG Lifesciences India reports consolidated net loss of Rs 3.65 crore in the March 2024 quarter
( Results - Announcements 31-May-24 07:36 )
ANG Lifesciences India schedules board meeting
( Corporate News - 26-May-23 10:15 )
ANG Lifesciences India to conduct AGM
( Corporate News - 21-Sep-22 15:57 )
ANG Lifesciences India to hold EGM
( Corporate News - 06-Apr-23 17:33 )
ANG Lifesciences India to hold board meeting
( Corporate News - 01-Sep-23 11:12 )
Other Stories
TD Power Systems wins order of USD 9.28 million
02-Jul-24 18:49
We Win wins contract of Rs 13.39 cr
02-Jul-24 18:42
DE Nora India wins order of Rs 38.71 cr
02-Jul-24 18:37
CFF Fluid Control wins contract of Rs 10.46 cr
02-Jul-24 18:36
Dev Information Technology wins orders worth Rs 8 cr
02-Jul-24 18:35
IEX records 24.7% growth in electricity volume in June
02-Jul-24 18:27
K E C International wins orders of Rs 1,017 cr
02-Jul-24 18:25
C-DAC partners with MosChip and Socionext
02-Jul-24 18:22
Inox India receives credit ratings for bank facilities
02-Jul-24 17:50
HCL Technologies launches new global delivery center in Patna
02-Jul-24 17:44
Back
Top
